To measure the variation of the[0020]RFC activity in lymphocytes by MTX administration

To measure the variation of the[0020]RFC activity in lymphocytes by MTX administration - To measure the variation of the[0020]RFC activity in lymphocytes by MTX administration

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021736

Enrollment

Registered

2016-04-01

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

blood examination study duration: 1years

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient to start the administration of MTX

Exclusion criteria

Exclusion criteria: Patients who doctors determined to be inappropriate as a subject.

Design outcomes

Primary

Measure	Time frame
To measure the variation of the[0020]RFC activity in lymphocytes by MTX administration	—

Countries

Japan

Contacts

Public ContactSeiji Tsuboi

Shizuoka Kousei Hospital rheumatology

ja-sizukousei-ra@krc.biglobe.ne.jp054-271-7177

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026